In particular, in reductionist in vitro studies, we found that low arginine may protect MM cells from drug-induced cell death, an effect accounted for by increased mTORC2-driven AKT activity, and possibly, at least in part, by heightened BAD phosphorylation. The gene discussed is BAD; the disease is Miyoshi myopathy.